What is Xeomin?
Xeomin (incobotulinumtoxinA), is a neurotoxin approved by the US FDA for the treatment of moderate to severe frown lines in adults. Xeomin is made of a protein purified from the bacterium Clostridium botulinum. It acts in the same way as Botox to block nerve activity in the muscles, causing a temporary reduction in muscle activity, thus a reduction in wrinkles and lines.
Xeomin is the first Botulinum Toxin that does not need to be refrigerated before use. It has no additives, containing only Botulinum Toxin type A – this may mean there is less risk of developing antibodies against Xeomin compared to other available neurotoxins. The effects of Xeomin are visible within one week, with results lasting 3 to 6 months. Xeomin should not be used interchangeably with other botulinum products. There is a risk all botulinum toxin products may spread from the area injected, causing potentially life-threatening swallowing and breathing problems. Other risks may include bleeding and bruising at the injection site and allergic reactions such as itching, swelling or shortness of breath. You will need to fill out an informed consent form which outlines these possible side effects.